Search

Competing Interests: Conflicts of interest None disclosed.

Standards are a set of guidelines or criteria used to ensure consistency, quality, safety, and compatibility in products, services, and processes [...]

We are pleased to launch the inaugural issue of the UCSD Molecule Pages  .

Welcome to the inaugural issue of the College’s flagship journal with our new Editor-in-Chief, Dr Mark Avery. On behalf of all members, contributors and readers we wish him and the editorial team all the best. Firstly, I would like to thank all members and all those health professionals across our regions for your dedicated service, commitment and support of the community in the past two years during the COVID-19 Pandemic. In Australia we have also seen natural disasters add to workloads and from time to time it really is important to take a moment to acknowledge the fantastic job being done managing through these crises. Thank you. We now have some wonderful analysis from the vast number of College members who have completed the self-assessment against the ACHSM Master Health Service Competency Framework. This report was generated in October last year with 864 overall completions, 732 of those from Australia. Thanks to The Screening Lab who provide the platform for this self-assessment survey and have generated this report from your feedback.....

Dear Readers, The German Journal of Pharmaceuticals and Biomaterials (GJPB) is a new journal published in Germany that focuses on Pharmaceutical Sciences and Biomaterials. This journal is neither beholden to commercial interests nor a scientific organisation and is, therefore, free to respond to the demands of writers and readers and offers a genuinely cost-effective publication service. GJPB is a quarterly publication covering all disciplines linked to Pharmaceutical Sciences and Biomaterials. It appeals to both specialised and multidisciplinary interests. The journal publishes research papers and reviews the current state of the art in Pharmaceutical Sciences and Biomaterials. Articles on Pharmaceutical/Biomaterial research, teaching & learning, laboratory innovations, education technology, and other related topics will be presented. Fair and open review methods for acceptability and a double-blind refereeing system are other significant elements of GJPB. The publication of the journal is free of charge. It is an excellent opportunity to try out this journal and take advantage of free publication. The papers will be evaluated by the Editorial Board and a vast panel of reviewers. Members of the Editorial Board and reviewer panel are recruited worldwide and have expertise in Pharmaceutical Sciences and Biomaterials. I guarantee a timely, courteous, and unbiased review of your paper based on clearly defined acceptable standards. I am glad to extend a warm welcome to you at the inauguration of the "German Journal of Pharmaceuticals and Biomaterials". I want to express my gratitude to the entire team, as they are the backbone of this scientific endeavour.

This document is a presentation of the inaugural issue of the series Management Sciences published in the review Economies and Societies in April 1979. The document emphasizes the importance of specialized research in management and economics, highlighting the need for researchers to apply their time and energy to improve organizational productivity and human resource development. It also discusses the role of economic theory and the limitations of neo-classical theories in understanding organizations and entrepreneurs. The document concludes by stating that the new journal will contribute to the deepening of the field and the coherence of the fundamental theory of economic activity. [Extracted from the article]